Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 33 Issue 12, December 2015

A colored scanning electron micrograph of hematopoietic stem cells. Cannon and colleagues report efficient genome editing in human hematopoietic stem and progenitor cells using zinc finger nuclease mRNA and AAV6 donor DNA (p 1256). Credit: SPL/Science Source

Editorial

  • Here's hoping that a proposed shakeup of US regulations will mean that new biotech products avoid AquaAdvantage salmon's two-decade upstream struggle to regulatory approval.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Bioentrepreneur

  • How the sharing economy is influencing biotech innovation and what it means for startups.

    • Samuel K Sia
    • Matthew P Owens
    Bioentrepreneur
Top of page ⤴

Correspondence

Top of page ⤴

Patents

Top of page ⤴

News & Views

  • An approach for efficient genome editing in human hematopoietic stem cells could be useful in the treatment of immunological disorders.

    • Giorgia Santilli
    • Adrian J Thrasher
    News & Views
  • Use of sophisticated reductionist and whole-system approaches are providing much-needed technologies to unravel the complex mélange of microbiome functions.

    • Dylan Dodd
    • Carolina Tropini
    • Justin L Sonnenburg
    News & Views
  • Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.

    • Erik J Sontheimer
    • Scot A Wolfe
    News & Views
Top of page ⤴

Analysis

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Careers and Recruitment

  • Careers and Recruitment
Top of page ⤴

Search

Quick links